Global soft tissue allografts market to register 7% CAGR through 2026

May 19, 2020


As per the report titled ‘Global Soft Tissue Allografts Market Size study, by Type (Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft, Others), by Application (Orthopedic, Dentistry, Wound Care, Others), by End-User (Hospitals, Aesthetic Centers, Orthopedic Clinics, Dental Clinics, Others) and Regional Forecasts 2020-2026’, available with Market Study Report LLC, global soft tissue allografts market share was valued at USD 4 billion in 2019 and is projected to record a y-o-y growth rate of 7% over 2020-2026.
 

Soft tissue allografts are substitute tissues mainly used in medical procedures such as spinal surgery, reconstruction of deficient ligaments, torn menisci, and osteochondral defects in knee surgery. These allografts are mostly made up of tendons, skin, veins, heart valves and cartilage, and are used for transplant in distinct surgeries.
 

Increasing cases of degenerative joint disorders and growing geriatric population who are highly susceptible to various physical ailments are the major growth drivers of global soft tissue allografts market. According to a study published by Transplant Department of Cleveland Clinic, U.S, about 30,000 surgeries requiring allograft tissue are performed each year in the clinics, including anterior cruciate ligament procedures and meniscal transplants. Similarly, as per World Health Organization (WHO), 18% women and 9.6% men aged above 60 years are suffering from symptomatic osteoarthritis.  
 

Furthermore, escalating demand for soft tissue allografts from athletic patients is enhancing the market growth. However, high treatment cost and poor reimbursement scenario may hinder the market growth over the forecast period.
 

From a regional perspective, the market is segmented into North America, Asia Pacific, Europe, Latin America and Rest of the World. North America soft tissue allografts market is anticipated to show strong growth trends over the forecast timeline. The growth can be attributed to increased pervasiveness of diabetic foot ulcers, various disease awareness program by healthcare institutes, and rising number of surgeries for anterior cruciate ligament (ACL) across the region.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2610777/
 

Meanwhile, soft tissue allografts market in Asia Pacific is poised to see considerable growth during the assessment period, owing to rise in number of tissue banks and increasing aging population in nations like India and China
.

Key players in global soft tissue allografts market are Xtant Medical Holdings, Inc., B. Braun Melsungen AG, Alon Source Group, Allergan Plc, CONMED Corporation, Alliqua BioMedical, Inc., Becton Dickinson and Company, Bone Bank Allografts, Arthrex, Inc., and Integra LifeSciences Corporatio